secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001193125-24-025951
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Disc Medicine appoints Jean Franchi as CFO effective Feb 7, 2024; promotes Jonathan Yu to COO
--------------------------------------------------------------------------------

- Jean Franchi appointed CFO, replacing Joanne Bryce who transitions to consulting; effective Feb 7, 2024.
- Franchi receives $515k base salary, $75k signing bonus, 40% target bonus; inducement equity: option for 55k shares and RSU for 36,666 shares.
- Franchi brings 30+ years experience; previously CFO at Replimune, Merrimack, Dimension Therapeutics, and Genzyme.
- Jonathan Yu promoted from Chief Business Officer to COO effective Feb 7, 2024.
- Equity inducement awards granted outside the 2021 stock plan per Nasdaq Listing Rule 5635(c)(4).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/d758257d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-025951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer